Viveo 2Q26 net loss narrows 51,4% to R$ 34,65 juta; revenue rises 3,4% to R$ 2,91 miliar

• CM Hospitalar SA posted 2Q26 net revenue of R$ 2,91 miliar, up 3,4% year-on-year.
• Net loss narrowed to R$ 34,65 juta from a year earlier, while adjusted net loss improved to R$ 21,27 juta.
• Adjusted EBITDA rose 21,8% to R$ 216,68 juta, lifting the adjusted EBITDA margin by 1,1 percentage points to 7,4%.
• Free cash flow fell 29,4% to R$ 124,77 juta, while the cash conversion cycle improved to 53 days, down 4 days.
• Management cited selective growth and margin expansion; net debt/adjusted EBITDA ended at 3,73x after June’s debt maturity extension.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CM Hospitalar SA published the original content used to generate this news brief on August 11, 2026, and is solely responsible for the information contained therein.